²é¿´: 1034  |  »Ø¸´: 0

lyh1228

гæ (³õÈëÎÄ̳)

[½»Á÷] ÖÐɽ´óѧ¸ßнÕÐƸÖúÑкͲ©ºó

¾ßÌ幤×÷µØµã:
ÉîÛÚ
н½ð:
ÃæÒé

ÖÐɽ´óѧ¸½ÊôµÚÆßÒ½Ôº¿ÆÑÐÖÐÐÄ»ÆóÙ»ÔÑо¿Ô±/¿µÑó¸±Ñо¿Ô±¿ÎÌâ×éÁªºÏÕÐƸÆôÊÂ

Òò¿ÆÑй¤×÷ÐèÒª£¬ÖÐɽ´óѧ¸½ÊôµÚÆßÒ½Ôº»ÆóÙ»Ô½ÌÊÚ/¿µÑ󸱽ÌÊÚ¿ÎÌâ×éÄâÁªºÏÕÐƸÖúÀíÑо¿Ô±2Ãû£¬²©Ê¿ºóÊýÃû¡£ÏêÇéÈçÏ£º
I.        ¿ÎÌâ×é¼ò½é£º
1.1 »ÆóÙ»ÔÑо¿Ô±¿ÎÌâ×飺
»ÆóÙ»Ô²©Ê¿£¬ÖÐɽ´óѧµÚÆ߸½ÊôÒ½Ôº¿ÆÑÐÓë¹ú¼Ê½»Á÷ÖÐÐÄÑо¿Ô±¡¢½ÌÊÚ¡¢²©Ê¿Éúµ¼Ê¦¡£ÖÐɽ´óѧº£Íâ¸ß²ã´ÎÒý½øÈ˲š£Ô­ÃÀ¹úҽѧ¿ÆѧԺ£¨NIH£©¶ùͯ½¡¿µÓëÈËÀà·¢Õ¹Ñо¿ËùÖúÀíÑо¿Ô±£¬ÏȺó»ñµÃÃÀ¹úŦԼ´óѧ (New York University) Àíѧ˶ʿ¡¢¿µÄζû´óѧ£¨Cornell University£©²©Ê¿Ñ§Î»£¬²¢ÔÚҮ³´óѧ(Yale University) Íê³É²©Ê¿ºóÅàѵ¡£Ê¦´Ó¿µÄζû´óѧҽѧԺ¸±Ôº³¤£¬Ï¸°ûÓë·¢ÓýÉúÎïѧϵϵÖ÷ÈÎKatherine A. Hajjar½ÌÊÚ£¬¼°Ò®Â³´óѧҩѧϵ¸±Ö÷ÈΣ¬Ñª¹ÜÉúÀíºÍÖÎÁÆÑо¿ÖÐÐÄÖ÷ÈÎWilliam Sessa½ÌÊÚ¡£ÏȺóÔÚScience, Nature Medicine, Nature Immunology, Journal of Clinical Investigation, BloodµÈ¸ßÓ°ÏìÒò×ÓѧÊõÆÚ¿¯·¢±íѧÊõÂÛÎÄ£¬²¢Ó¦Ñûµ£ÈÎFrontier in Oncology, Frontier in Immunology¿Í×ùÔðÈα༭, ͬʱ»¹¼æÈÎCancer Immunology Immunotherapy, JCI insight, Cancer Letter, Tumor Biology, Journal of Surgical Oncology, Journal of CancerµÈѧÊõÔÓÖ¾Éó¸åÈË¡£¸ü¶àÏêÇ飬Çë²Î¿¼£ºhttp://www.sysush.com/content/6bb2b154-c325-42b0-a124-0c2ded3c62dd

1.2 ¿ÎÌâ×éÖ÷ÒªÑо¿·½ÏòÊÇ£¨µ«²»¾ÖÏÞÓÚ£©ÒÔÏÂÈý¸öÁìÓòµÄ¿ÎÌ⣺
1£©Bϸ°û¼¤»î·Ö»¯µÄµ÷¿ØлúÖÆ£»
2£©Ö×ÁöÒìÖÊÐÔ¼°ÃâÒß΢»·¾³¶ÔÖ×ÁöÄÍÒ©ºÍÉú³¤µÄÓ°Ï죻
3£©ÃâÒßË¥ÀϵķÖ×Ó»úÖƼ°ÔÚ¶àÖÖ¼²²¡·¢ÉúÖеÄ×÷Óá£

1.3´ú±íÐÔÂÛÎÄ
1£©Huang B, et al. (2022) Science Immunology (under revision) (IF=17.727)
2£©Huang B, et al. (2017).  Nature Medicine 23(1):128-135 (IF=53.44)
3£©Huang B, et al. (2011).  Blood 118(10): 2918-29. (IF=22.113)
4£©Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, He B, Cassis L, Bigas A, Cols M, Comerma L, Huang B, Blander JM, Xiong H, Mayer L, Berin C, Augenlicht LH, Velcich A, Cerutti A. (2013).  Science 342(6157):447-53. (IF=41.845)
5£©Hong P, Chen K, Huang B, Liu M, Cui M, Rozenberg I, Chaqour B, Pan X, Barton ER, Jiang X, Siddiqui MAQ (2012).  Journal of Clinical Investigation 122(11): 3873-87. (IF=14.808)
6£©Chen K, Xu W, Wilson M, He B, Miller NW, Bengten E, Edholm E-S, Santini PA, Rath P, Chiu A, Cattalini M, Litzman J, Bussel J, Huang B, Meini A, Riesbeck K, Cunningham-Rundles C, Plebani A, Cerutti A (2009).  Nature Immunology 10:889-898. (IF=25.606)
7£©Cesarman-Maus G, R¨ªos-Luna NP, Deora AB, Huang B, Villa R, Cravioto Mdel C, Alarc¨®n-Segovia D, S¨¢nchez-Guerrero J, Hajjar KA. (2006).  Blood 107 (11): 4375-4382. (IF=22.113)

1.4 ÆäËü
±¾¿ÎÌâ×é2019Äê³ÉÁ¢£¬ÔÚ²»µ½3Äêʱ¼äÒÑ˳Àû»ñµÃ¹ú×ÔÈ»ÃæÉÏ»ù½ð2Ï¹ã¶«Ê¡ÇàÄê»ù½ð1ÏÉîÛÚÊÐÃæÉÏ»ù½ð2Ï¹ú¼Ò²©Ê¿ºó»ù½ð1Ïî×ÊÖú¡£Ä¿Ç°¿ÎÌâ×éÓв©Ê¿ºó1Ãû£¬²©Ê¿Ñо¿Éú6Ãû£¬Ë¶Ê¿Ñо¿Éú3Ãû£¬»¹½«Óë¹úÄÚÍâ¶àËùÖªÃûԺУºÍ¿ÆÑлú¹¹Èç¹þ·ð´óѧ¡¢Ò®Â³´óѧ¡¢¿µÄζû´óѧ¡¢NIH£¬ºÍ¶«¾©´óѧ¿ªÕ¹¹ã·ººÍÉîÈëµÄºÏ×÷£¬¹²Í¬Íƽø¿ÎÌâ½øÕ¹¡£¿ÎÌâ×é³ÉÔ±ÄêÇáÇÒÓлîÁ¦£¬±ü³Ð»îÁ¦¿ÆÑк͹«Æ½¹«ÕýµÄÔ­Ôò£¬Õæ³ÏÏ£Íû¸÷λÓÐÖ¾ÇàÄê²Å¿¡¼ÓÃËÎÒÃÇÕâ¸öеļÒÍ¥£¬ÆÚ´ýÄúµÄµ½À´£¡

2.1 ¿µÑó¸±Ñо¿Ô±¿ÎÌâ×飺
¿µÑó²©Ê¿£¬ÖÐɽ´óѧ¸½ÊôµÚÆßÒ½Ôº¸±Ñо¿Ô±£¬Ë¶Ê¿Éúµ¼Ê¦£¬ÖÐɽ´óѧ¡°°ÙÈ˼ƻ®¡±ÇàÄêѧÊõ¹Ç¸ÉÒý½øÈ˲ţ¬ÉîÛÚÊС°ÓÅÇà¡°ÏîÄ¿»ñµÃÕß¡£ËÄ´¨´óѧ±¾¿Æ£¬Öйú¿ÆѧԺ´óѧ²©Ê¿£¬±±¿¨ÂÞÀ´ÄÉÖÝÁ¢´óѧ·ÃÎÊѧÕß¡£

±¾¿ÎÌâ×éÑо¿·½ÏòΪÉúÎïҽѧÏȽø²ÄÁÏ£¬¾ßÌåÑо¿ÏȽø²ÄÁÏÔÚÖ×ÁöÃâÒß¡¢Ö×Áö¼ì²â¡¢Ö×ÁöÖÎÁÆ¡¢¿ÉÊÓ»¯¸øҩϵͳÖеÄÓ¦Ó᣽üÄêÀ´Ö÷Òª¹¤×÷¼¯ÖÐÓÚÐÂÐʹ̼¤ÏìÓ¦ÐÔÄÉÃ×µÝËÍÌåϵµÄ¿É¿Ø¹¹Öþ¼°¼²²¡ÕïÁÆÓ¦Óá£Ä¿Ç°ÀÛ»ý·¢±íÂÛÎÄ40Óàƪ£¬ÆäÖÐÒÔµÚÒ»×÷Õß/ͨѶ×÷Õß·¢±íÂÛÎÄ30Óàƪ¡£Ïà¹Ø³É¹ûÒÔµÚÒ»/ͨѶ×÷Õß·¢±íÔÚ¶¥¼¶Ñ§Êõ¿¯ÎïAdvanced Materials, Advanced Functional MaterialsµÈ¡£»¶Ó­¾ßÓл¯Ñ§¡¢²ÄÁÏ¡¢ÉúÎҽѧ¡¢ÃâÒßµÈÏà¹Ø±³¾°µÄѧÉú¼ÓÃË¿ÎÌâ×飬Ҳ»¶Ó­±¾Ð£±¾¿ÆÉú²ÎÓë¿ÎÌâÑо¿£¬É걨´óѧÉú´´Ð¼ƻ®£¬Íê³É±ÏÒµÂÛÎÄ¡£±¾¿ÎÌâ×é³£ÄêÕÐƸ²©Ê¿ºó£¬ÌṩÁ¼ºÃ¿ÆÑл·¾³¡£ÖÐɽ´óѧ¸½ÊôµÚÆßÒ½Ôº½üÄêÀ´·¢Õ¹Ñ¸ËÙ£¬ÓÅÐ㲩ʿºóÓнϴó»ú»áÁôÔº¼ÌÐø¹¤×÷¡£ÏêÇé²Î¿¼£ºhttp://www.sysush.com/content/7261bfe1-515d-4d07-825b-2d5687d85bcb

2.2 ½ü3Äê´ú±íÐÔÂÛÎÄ
1.        Smart nanocarriers as therapeutic platforms for bladder cancer. Nano Research. 2021, https://doi.org/10.1007/s12274-021-3753-9. £¨IF£º8.897£©
2.        Dual pH- and glutathione-responsive CO2-generating nanodrug delivery system for contrast-enhanced ultrasonography and therapy of prostate cancer. ACS Applied Materials & Interfaces. 2021, 13, 12899-12911. £¨IF£º9.229£©
3.        Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy. Materials Science & Engineering C, 2021, 123, 111956. £¨IF£º7.328£©
4.        Engineered PD-L1-Expressing platelets reverse new-onset type 1 diabetes. Advanced Materials, 2020, 32, 1907692. £¨IF£º30.849£©
5.        Nano drug carrier based on poly(ursolic acid) with self-anticancer activity against colorectal cancer. Advanced Functional Materials, 2020, 30, 1907857. £¨IF£º18.808£©
6.        Redox-Responsive self-assembled nanoparticles for cancer therapy. Advanced Healthcare Materials, 2020, 2000605. £¨IF£º9.933£©

II.        ÕÐƸҪÇó£º
1. ÖúÀíÑо¿Ô±£¨2Ãû£©£º
1£©ÃâÒßѧ·½Ïò£¨1Ãû£©£ºÃâÒßѧ¡¢·Ö×ÓÓëϸ°ûÉúÎïѧµÈÏà¹Øרҵ²©Ê¿Ñ§Î»£¬ÊìϤÉúÎïÐÅÏ¢·ÖÎöÕß¼Ó·Ö£»
2£©ÉúÎï²ÄÁÏ·½Ïò£¨1Ãû£©£º»¯Ñ§¡¢Ò©Ñ§¡¢¸ß·Ö×ÓµÈÏà¹Øרҵ²©Ê¿Ñ§Î»£¬ÓÐÉúÎï²ÄÁÏÑо¿¾­ÑéÕß¼Ó·Ö£»
3£©Óв©Ê¿ºó¾­ÀúÕßÓÅÏÈ£»
4£©²©Ê¿»ò²©Ê¿ºóÆڼ䣬ÔøÒÔµÚÒ»×÷ÕßÉí·Ý·¢¹ýSCIÂÛÎÄ£¨IF¡Ý5·Ö£©£»
5£©¾ßÓжÀÁ¢Íê³É¿ÎÌâÉè¼ÆºÍʵÑéµÄÄÜÁ¦£»
6£©ÊìÁ·¸÷ÖÖ³£Óø߷Ö×ӺϳɻòÉúÎïʵÑé¼¼Êõ£»
7£©¾ß±¸Á¼ºÃµÄÓ¢ÓïÌý¡¢Ëµ¡¢¶Á¡¢Ð´ÄÜÁ¦£»
8£©ÄêÁäÔ­ÔòÉÏÔÚ38ËêÒÔÏ¡£

2. ²©Ê¿ºó£¨ÊýÃû£©£º
1£©        »¯Ñ§¡¢ÃâÒßѧ¡¢Ò©Ñ§¡¢Ï¸°ûÉúÎïѧµÈÏà¹Øרҵ²©Ê¿Ñ§Î»£»
2£©        ²©Ê¿Æڼ䣬µÚÒ»×÷ÕßÉí·Ý·¢¹ýSCIÂÛÎÄ£¨IF¡Ý3·Ö£©£»
3£©        ¾ßÓжÀÁ¢Íê³É¿ÆÌâÉè¼ÆºÍʵÑéµÄÄÜÁ¦£»
4£©        ÊìÁ·¸÷ÖÖ³£¼û»¯Ñ§ÊµÑé²Ù×÷£¬»ò³£ÓÃÉúÎïʵÑé¼¼Êõ£¬ÓÈÆäÊǶ¯ÎïʵÑéÄÜÁ¦ºÍÁ÷ʽϸ°ûѧ¼¼Êõ£»
5£©        ¾ß±¸Á¼ºÃµÄÓ¢ÓïÌý¡¢Ëµ¡¢¶Á¡¢Ð´ÄÜÁ¦£»
6£©        ÄêÁäÔ­ÔòÉÏÔÚ35ËêÒÔÏ¡£

III. ¸ÚλְÔð
1¡¢¶ÀÁ¢³Ðµ£Ïà¹Ø¿ÎÌ⣬ÕùÈ¡·¢±í¸ßˮƽ¿ÆÑÐÂÛÎÄ£»
2¡¢»ý¼«ÉêÇë¸÷Àà»ù½ðÏîÄ¿£»
3¡¢Íê³ÉÑо¿ÍŶӵIJ¿·Ö½ÌѧÈÎÎñ£»
4¡¢Ð­ÖúÍŶӹÜÀíºÍÖ¸µ¼Ñо¿ÉúÍê³ÉÔÚÑпÎÌâµÈÓйع¤×÷¡£

IV. ´ýÓö£º
1. н³ê£ºÖúÀíÑо¿Ô±Äêн£º38-44Íò×óÓÒ£¨º¬Ò½ÔºÎåÏÕÒ»½ð£©£»        ²©Ê¿ºóÄêн35-45Íò£¨Ë°Ç°£©£¬ÔÚ×îÐÂQS¡¢TIMESµÈÊÀ½ç´óѧÅÅÐаñÇ°150ÃûµÄ¸ßУ²©Ê¿±ÏÒµÉú»òÔÚÔøÒÔµÚÒ»×÷Õß·¢±íIF5.0¼°ÒÔÉϵÄÎÄÕ£¬¶îÍâÔö¼Ó3ÍòÔªµÄ¼¨Ð§¹¤×Ê£»
2.        ЭÖúÉêÇëÉîÛÚÊÐÔÚÕ¾²©Ê¿ºóÉú»î²¹Ìù£¨2Äê¹²12ÍòÔª£©
3.        ÔÚÕ¾Æڼ䷢±íÎÄÕÂÒÔ¼°ÉêÇëµ½Òý½øÏîÄ¿»ò¿Æѧ»ù½ðµÈ×ÊÖú°´Ò½Ôº¿ÆÑн±ÀøÕþ²ßÁíÏí¸ß¶î½±Àø
4.        ²©Ê¿ºóÿÄê¿É»ñµÃ10ÍòÔª¿ÆÑÐ×ÊÖú¡£
5.        Èç³É¹¦ÉêÇ벩ʿºóÏîÄ¿½øÕ¾£¨²©Ê¿ºó´´ÐÂÈ˲ÅÖ§³Ö¼Æ»®¡¢²©Ê¿ºó¿Æѧ»ù½ðÌرð×ÊÖú(վǰ)¡¢Ï㽭ѧÕ߼ƻ®¡¢°ÄÃÅÇàÄêѧÕ߼ƻ®¡¢Öе²©Ê¿ºó½»Á÷ÏîÄ¿¡¢¹ã¶«Ê¡º£ÍâÇàÄ격ʿºóÒý½øÏîÄ¿¡¢²©Ê¿ºó¹ú¼Ê½»Á÷¼Æ»®Òý½øÏîÄ¿£©£¬Äêн½«Ôö¼Ó5-15ÍòÔª¡£
6.        ÌṩÉîÛÚÊÐÈ˲Ű²¾Ó·¿£¨2¾ÓÊÒ»òÕß3¾ÓÊÒ£©£¬°²ÅÅ×ÓÅ®Èëѧ¡£²©Ê¿ºó¿ÉÉêÇ벩ʿºóÆô¶¯¾­·Ñ60ÍòÈËÃñ±Ò£¬ÓÅÐãÕ߿ɱ£Ë͵½º£Íâ¸ß¶ËʵÑéÊÒÁªºÏÅàÑø£¬×¿Ô½³öÕ¾Õß¿ÉÍƼöµ½ÖÐɽÆßÔº¸ß¼¶Ö°³Æ¸Úλ¡£ÖúÀíÑо¿Ô±ºÍ²©Ê¿ºóÔÚÏîÄ¿¿ÎÌâÆô¶¯ºÍÍƽøÉÏÓжÀ´´¹±Ï×Õß¿ÉÍâ¼Ó¹²Í¬Í¨Ñ¶×÷ÕßÊðÃûÎÄÕ£¬Èç¹ûÉêÇëµ½¶ÀÁ¢¾­·Ñ£¬¿ÎÌâ×éÖ§³Ö¶ÀÁ¢·¢ÎÄÕºÍ×齨ÍŶӣ¬»¥Àû¹²Ó®¡£ÁíÍ⣬³ýÁËÄÜÄõ½ÆßÔºµÄÏà¹Ø´ýÓö£¬»¹ÓпÉÄÜÉêÇëµ½ÉîÛÚÊи߲ã´ÎÈ˲š£2021ÄêÉîÛÚÊи߲ã´ÎרҵÈ˲ÅÈ϶¨½±Àø²¹Ìù¡¢¹ú¼Ò¡¢µØ·½¼¶Áì¾üÈ˲š¢ºó±¸¼¶È˲ÅÈ϶¨±ê×¼£ºhttp://www.gaoxinbutie.com/rending/

V. ÁªÏµ·½Ê½
ӦƸÕßÇ뽫¸öÈ˼òÀú£¨½ÌÓý¾­Àú¡¢¹¤×÷¾­Àú¡¢·¢±íÂÛÎÄ¡¢ÈÙÓþ½±ÀøµÈ£©¡¢´ú±íÐÔÂÛÎĵÄÈ«ÎĵȲÄÁÏe-mailÖÁÁªÏµÈË
ÁªÏµÈË£º»ÆÀÏʦhuangbh7@mail.sysu.edu.cn£»¿µÀÏʦ kangy26@mail.sysu.edu.cn

[ À´×Ô°æ¿éȺ ¹ã¶« ]
ËæÔµ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌøת ÎÒÒª¶©ÔÄÂ¥Ö÷ lyh1228 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[»ù½ðÉêÇë] 2024¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð×ÊÖú¶î¶È +5 i6277 2024-05-05 5/250 2024-05-05 19:35 by hktk1987
[ÂÛÎÄͶ¸å] Optics ExpressÒ»Ö±¿¨ÔÚFinal Decision +3 MissPro 2024-05-05 6/300 2024-05-05 19:18 by MissPro
[»ù½ðÉêÇë] ÌØƸ½ÌÊÚ£¬Ëã¸ß¼¶Ö°³ÆÂð£¿ÇàÄê»ù½ð»¹Ã»½áÌâµÄÇé¿öÏ»¹Äܱ¨ÃæÉÏÂ𣿠+7 aasahr 2024-05-05 8/400 2024-05-05 18:57 by wspglt
[¿¼²©] 25Äê´ºÇﲩʿÉêÇë +3 ÃÎÏëÑо¿Éú 2024-05-04 5/250 2024-05-05 15:49 by ÃÎÏëÑо¿Éú
[˶²©¼ÒÔ°] ÕÒ¹¤×÷ǧÍò²»ÄÜÀ´²îѧУ +9 YNÍêµ° 2024-05-02 9/450 2024-05-05 13:24 by ϪɽÓοÍ
[˶²©¼ÒÔ°] ´ó¼ÒÄܲ»ÄܸøµãÒâ¼û°¡ +8 ÊÇСÂìÒÏÀ² 2024-05-01 16/800 2024-05-05 11:01 by ÊÇСÂìÒÏÀ²
[Óлú½»Á÷] DMFÔõô³ýË® +7 °®³ÔÏã²ËµÄС»Æ¹ 2024-05-01 12/600 2024-05-05 10:53 by ppttjjboy
[½Ìʦ֮¼Ò] ²©Ê¿±ÏÒµÕÒ¹¤×÷Ñ¡Ôñ£¡ +9 gsqºÙºÙ 2024-04-30 12/600 2024-05-05 09:21 by Nano-Firefly
[¿¼ÑÐ] Òª²»Òª¶þÕ½£¿ +5 ajjznskk 2024-05-05 5/250 2024-05-05 09:02 by »¨ÂúÂ¥Gsir
[½Ìʦ֮¼Ò] Æß¼¶¸Ú£¬µ½ÊÖ²»µ½8000£¬´ø±¾¿ÆÂÛÎÄ12½Ìѧ·Ö/Éú£¬¶î¶¨½Ìѧ·Ö280 +20 ºÓÎ÷Ò¹ÀÉ 2024-05-02 23/1150 2024-05-05 08:57 by Quakerbird
[½Ìʦ֮¼Ò] ˵ͬѧ¶Ô´ý±ÏÒµÂÛÎIJ»ÈÏÕæºóËýºÜ²»Ôà +13 ºÓÎ÷Ò¹ÀÉ 2024-04-30 16/800 2024-05-05 07:22 by Finnhu
[»ù½ðÉêÇë] »îÒ³³¬¹ý7000×Ö£¬ÓÐÓ°ÏìÂ𣿠+4 ÇàÖñ82 2024-05-04 5/250 2024-05-04 23:28 by »ªÊÏ911.
[ÂÛÎÄͶ¸å] Éó¸åÈËÆÀÉóÍê³É״̬»¹ÊÇunder review 5+3 ZH0826 2024-04-30 10/500 2024-05-04 21:05 by topedit
[»ù½ðÉêÇë] ¹ØÓÚ¹«²¼2024Äê¶È¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿ÉêÇë³õÉó½á¹ûµÄͨ¸æ (½ð±Ò+2) +12 hdzw9071 2024-04-30 18/900 2024-05-04 17:49 by felicity6056
[¿¼²©] ±±¾©Ê¦·¶´óѧÈ˹¤ÖÇÄÜѧԺ2024ÄêµÚ¶þÅú²©Ê¿Ñо¿ÉúÕÐÉú±¨Ãû +4 taoto 2024-05-02 5/250 2024-05-04 15:46 by LYS1200
[¿¼²©] ʳƷרҵѰ²©Ê¿µ¼Ê¦ +3 ÀïÊÏʲôÀâ 2024-04-29 6/300 2024-05-04 08:00 by ŬÁ¦°áשÖÐѽ
[»ù½ðÉêÇë] ½ñÄêÃæÉÏÔ¤¼ÆÓÖ´ò½´ÓÍÁË +15 speedxyl 2024-04-30 17/850 2024-05-04 02:07 by jbb0523
[ÎÞ»ú/Îﻯ] ¹ýÑõ»¯ÇâÑõ»¯ 10(½ð±Ò+5) +3 15132328891 2024-04-29 6/300 2024-05-03 13:39 by tan151646
[¸ß·Ö×Ó] ¸ß·Ö×Ó¾ÛºÏÎïÓлú²ÄÁÏ·½ÏòµÄºÏ×÷/ÕÐƸ¿ÆÑÐÖúÀí +3 wwwzg 2024-05-01 3/150 2024-05-02 21:38 by Dr. Zhang
[ÂÛÎÄͶ¸å] ÇóÖú£¬ÂÛÎÄСÐÞ·µÐÞÒÔºóScholarOneÉó¸åϵͳ ״̬ 20+5 15546226191 2024-04-30 9/450 2024-05-02 12:28 by ca0yan9
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û